Clinical Trials
134 trialsPerioperative Immunotherapy for NSCLC (ECTOP-1030)
Fudan University
Lung Cancer Screening CT for Firefighters
University of California, San Francisco
INDIGO
Gustave Roussy, Cancer Campus, Grand Paris
AI-Lung
University of Florida
Vaccination of Advanced-Stage Lung Cancer Patients
University of Arkansas
Defining Musical Toxicity and Its Effect on Patient Well-being
Mayo Clinic
Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
City of Hope Medical Center
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Rutgers, The State University of New Jersey
Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
ELEVATE
Prisma Health-Midlands
Bupivacaine Liposome Serrate Anterior Plane Block vs Traditional Thoracic Paravertebral Block
Shanghai Pulmonary Hospital, Shanghai, China
NEGOTIATE
Sun Yat-sen University
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
Sun Yat-sen University
APPEAL
Sun Yat-sen University
AERESA
Sun Yat-sen University
SBRT_LOV
Universitair Ziekenhuis Brussel
Non-linear Multimodal Microendoscopy for Lung Cancer Pathology
University Health Network, Toronto
Quantitative Lung Cancer Screening
University of Iowa
LC_ART
Abramson Cancer Center at Penn Medicine
Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study
M.D. Anderson Cancer Center
An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer
Roswell Park Cancer Institute
Re-Induce 2
Maastricht Radiation Oncology
SCION
University of British Columbia
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
University of Chicago
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
First Affiliated Hospital Xi'an Jiaotong University
GI Organ Tracking Via Balloon Applicators
Washington University School of Medicine
Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care
Medical University of Graz
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung
Ohio State University Comprehensive Cancer Center
INTRUSION
Erasmus Medical Center
A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations
M.D. Anderson Cancer Center
NSCLC
SCRI Development Innovations, LLC
NWA
Maimonides Medical Center
Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC
The Netherlands Cancer Institute
Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial
University of Washington
LUNG STAAR
Baptist Health South Florida
Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients
University of Hull
OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer
University of Washington
NNAL
University of Nebraska
HEPATICI
Centre Hospitalier Universitaire, Amiens
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors
M.D. Anderson Cancer Center
Technology-Based Cancer Screening Intervention
Medical University of South Carolina
CoVac-Lung
Guangdong Provincial People's Hospital
COFLEX-T
Washington University School of Medicine
Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer
University of California, Irvine
Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Roswell Park Cancer Institute
Tc99m Macroaggregated Albumin Bronchial Artery Study
Johns Hopkins University
Improving Survivorship Among Minority Cancer Dyads
Charles Drew University of Medicine and Science
Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study
M.D. Anderson Cancer Center
Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer
University of California, San Francisco